UTOZYME

Main information

  • Trade name:
  • UTOZYME FOAMING PESSARIES
  • Pharmaceutical form:
  • MISC. INTRA VAGINAL/UTERINE PREP/DEVICE
  • Units in package:
  • 20 pessary
  • Class:
  • Veterinary Medicine
  • Medicine domain:
  • Animals
  • Medicine type:
  • Allopathic drug

Documents

Localization

  • Available in:
  • UTOZYME FOAMING PESSARIES
    Australia
  • Language:
  • English

Therapeutic information

  • Therapeutic group:
  • CATTLE | GOAT | HORSE | PIGS | SHEEP | BEEF | BILLY | BOAR | BOS INDICUS | BOS TAURUS | BOVINE | BUCK | BUFFALO | BULL | BULLOCK
  • Therapeutic area:
  • antibiotic
  • Therapeutic indications:
  • METRITIS | VAGINAL LOCAL REACTANT | CLEANING UTERUS | ENTERITIS | INFECTIONS | LOCAL REACTANTS ON THE VAGINA | METRITIS | POST-NATAL | RETAINED PLACENTA | UTERUS | VAGINAL
  • Product summary:
  • As an aid in the post-natal treatment of infections, cleaning of the uterus, retained placenta and metritis of cattle, sheep, goats, pigs and horses.Any variation by the prescribing vet to the approved dose, frequency, duration, route, disease or target species may result in the need to extend the approved withholding time.

Other information

Status

  • Source:
  • Australian Pesticides and Veterinary Medicines Authority (APVMA)
  • Authorization status:
  • Registered and available
  • Authorization number:
  • 36317/0509
  • Authorization date:
  • 29-06-2009
  • Last update:
  • 15-06-2017

Patient Information leaflet: composition, indications, side effects, dosage, interactions, adverse reactions, pregnancy, lactation

PRESCRIPTION ANIMAL REMEDY

KEEP OUT OF REACH OF CHILDREN

FOR ANIMAL TREATM

ENT ONLY

UTOZYME

®

FOAMING PESSARIES

ACTIVE CONSTITUENT:

Each Pessary Contains:

500 mg OXYTETRACYCLINE

HYDROCHLORIDE

(Equivalent to 463.3 mg Oxytetracycline B.P.)

FOR INTRA-UTERINE USE

20 Pessaries

PRESCRIPTION ANIMAL REMEDY

KEEP OUT OF REACH OF CHILDREN

FOR ANIMAL TREATM

ENT ONLY

UTOZYME

®

FOAMING PESSARIES

ACTIVE CONSTITUENT:

Each Pessary Contains:

500 mg OXYTETRACYCLINE

HYDROCHLORIDE

(Equivalent to 463.3 mg Oxytetracycline B.P.)

FOR INTRA-UTERINE USE

20 Pessaries

INDICATIONS:

As an aid in the post-natal treatment of infections, cleaning

of the uterus, retained placenta and metritis of cattle, sheep,

goats, pigs and horses.

DIRECTIONS FOR USE:

Insert 1 pessary high into the uterus followed by 200 mL of

water at body temperature by catheter.

Any variation by the prescribing veterinarian to the approved

dose, frequency, duration, route, disease or target species may

result in the need to extend the approved withholding time.

WITHHOLDING PERIODS:

MEAT: DO NOT USE less than 14 days before slaughter

for human consumption.

MEAT (HORSES): DO NOT USE less than 28 days before

slaughter for human consumption.

MILK: Milk taken from animals within 36 hours following

a single treatment, or 3 days following the last of

multiple treatments, MUST NOT BE USED for human

consumption, or supplied for processing.

TRADE ADVICE

EXPORT SLAUGHTER INTERVAL (ESI): This product does

not have an ESI established. For advice on the ESI contact

Jurox Pty Ltd on 1800 023 312 before using this product.

STORE BELOW 25° (Air Conditioning)

KEEP IN A DRY PLACE

EXP.

FIRST AID: If poisoning occurs, contact a

doctor or the Poisons Information Centre.

Phone Australia 131 126

DISPOSE of packaging by wrapping

in paper and putting in garbage.

® Jurox Pty Ltd Registered Trade Mark

Made in Australia

408971

APVMA Approval No. 36317/20Pes/0509

Pty Ltd

85 Gardiner Road

Rutherford NSW 2320

Infoline 1800 023 312

UTOZYME

®

FOAMING PESSARIES

376.25mm

262mm

Overall size 376.25mm x 262mm

is 100% size

APVMA file name: 36317_47239_20Pes_primary_MPL_V01.pdf

Dimensions: primary pack = 376.25mm (wide) x 262mm (high)

Scale: 100% on A3

Date: 9 – 6 – 2009

APPROVED

LABEL

Info

pest

Verified

Repeated Element at 200%

FOR ANIMAL TREATMENT ONLY

UTOZYME

FOAMING PESSARY

500 mg OXYTETRACYCLINE HCI

406801

209.55mm repeat

100 mm web width

Unwind Direction

Print on Outside

PLEASE CHECK THIS PROOF CAREFULLY - PHARMAPRINT/TCA ACCEPT NO RESPONSIBILITY FOR ERRORS IN PROOF ONCE APPROVED BY CLIENT

Customer:

JUROX

Description:

UTOZYME FOAMING PESSARY

Customer Code:

406801

Code

Appears on Foil [ YES ] New [ X ] or Revision [ ]

Print Colours:

BLACK

Unwind Direction:

Pharmacode, Datamatrix etc:

Over-Lacquer [NO]

Eye Marks/Random: RANDOM

Repeat Tolerance (each repeat):

Repeat

Tolerance (multiple repeats):

Operator:

IAN CARTER

Date:

13/06/06

Version:

Job Bag No:

Z022

APR No:

2834

Client Approval of Proof

TCA Authorises Pharmaprint to proceed with making plate:

Sign:

Date:

Sign:

Date:

APVMA File Name: 36317_47239_[10][20]pes_immediate_MPL_V01.pdf

Dimensions: label = 100mm (high) x 209.55mm (wide)

Scale: 100% for A4

Date: 2/04/09

FOR ANIMAL TREATMENT ONLY

UTOZYME

FOAMING PESSARY

500 mg OXYTETRACYCLINE HCI

406801

FOR ANIMAL TREATMENT ONLY

UTOZYME

FOAMING PESSARY

500 mg OXYTETRACYCLINE HCI

406801

FOR ANIMAL TREATMENT ONLY

UTOZYME

FOAMING PESSARY

500 mg OXYTETRACYCLINE HCI

406801

FOR ANIMAL TREATMENT ONLY

UTOZYME

FOAMING PESSARY

500 mg OXYTETRACYCLINE HCI

406801

FOR ANIMAL TREATMENT ONLY

UTOZYME

FOAMING PESSARY

500 mg OXYTETRACYCLINE HCI

406801

FOR ANIMAL TREATMENT ONLY

UTOZYME

FOAMING PESSARY

500 mg OXYTETRACYCLINE HCI

406801

FOR ANIMAL TREATMENT ONLY

UTOZYME

FOAMING PESSARY

500 mg OXYTETRACYCLINE HCI

406801

FOR ANIMAL TREATMENT ONLY

UTOZYME

FOAMING PESSARY

500 mg OXYTETRACYCLINE HCI

406801

FOR ANIMAL TREATMENT ONLY

UTOZYME

FOAMING PESSARY

500 mg OXYTETRACYCLINE HCI

406801

FOR ANIMAL TREATMENT ONLY

UTOZYME

FOAMING PESSARY

500 mg OXYTETRACYCLINE HCI

406801

2-10-2018

Docetaxel Teva (Teva B.V.)

Docetaxel Teva (Teva B.V.)

Docetaxel Teva (Active substance: Docetaxel) - Centralised - Yearly update - Commission Decision (2018)6463 of Tue, 02 Oct 2018

Europe -DG Health and Food Safety

30-7-2018

Trazimera (Pfizer Europe MA EEIG)

Trazimera (Pfizer Europe MA EEIG)

Trazimera (Active substance: trastuzumab) - Centralised - Authorisation - Commission Decision (2018)5095 of Mon, 30 Jul 2018 European Medicines Agency (EMA) procedure number: EMEA/H/C/4463

Europe -DG Health and Food Safety

10-7-2018

Ninlaro (Takeda Pharma A/S)

Ninlaro (Takeda Pharma A/S)

Ninlaro (Active substance: ixazomib) - Centralised - Yearly update - Commission Decision (2018)4463 of Tue, 10 Jul 2018

Europe -DG Health and Food Safety

30-5-2018

Vokanamet (Janssen-Cilag International NV)

Vokanamet (Janssen-Cilag International NV)

Vokanamet (Active substance: canagliflozin / metformin hydrochloride) - Centralised - Yearly update - Commission Decision (2018)3463 of Wed, 30 May 2018

Europe -DG Health and Food Safety